Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis

Background: Chronic hepatitis C virus (HCV) infections are causally linked with metabolic comorbidities such as insulin resistance, hepatic steatosis, and dyslipidemia. However, the clinical impact of HCV eradication achieved by direct-acting antivirals (DAAs) on glucose and lipid homeostasis is sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Graf, Christiana, Welzel, Tania, Bogdanou, Dimitra, Vermehren, Johannes, Beckel, Anita, Bojunga, Jörg, Friedrich-Rust, Mireen, Dietz, Julia, Kubesch, Alica, Mondorf, Antonia, Fischer, Sarah, Lutz, Thomas, Stoffers, Philipp, Herrmann, Eva, Poynard, Thierry, Zeuzem, Stefan, Dultz, Georg, Mihm, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564474/
https://www.ncbi.nlm.nih.gov/pubmed/32825571
http://dx.doi.org/10.3390/jcm9092702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564474/
https://www.ncbi.nlm.nih.gov/pubmed/32825571
http://dx.doi.org/10.3390/jcm9092702

Ejemplares similares